Asundexian

3 trials 1 recruiting

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

2 Completed trials

1 Sponsors

22 Countries

Phase III

Phase I (Other)

Phase III: 2 Phase I (Other): 1

Indications tested

Cerebrovascular accident prophylaxis 2 Atrial fibrillation 1

Sponsors using this IMP

All trials

3 total

A study to learn about the amount of asundexian in the blood and the effect of food on its levels when healthy participants take it as adult… Recruiting

2025-523677-41-00 Phase I (Other) 1 country Bayer AG
A study to test asundexian for preventing a stroke caused by a clot in participants after an acute ischemic stroke or after a high-risk tran… Ended

2023-503793-20-00 Phase III 20 countries Bayer AG
A study to learn how well the study treatment asundexian works and how safe it is compared to apixaban to prevent stroke or systemic embolis… Ended

2023-503794-38-00 Phase III 22 countries Bayer AG

Showing 1–3 of 3 trials

← All drugs A–Z